Results 71 to 80 of about 29,013 (278)
In Vitro Hemocompatibility of the BiVACOR Total Artificial Heart in Continuous and Pulsatile Flow
Artificial Organs, EarlyView.BiVACOR's total artificial heart generates remarkably similar hemocompatibility when operated with a pulse or during continuous flow. Under both conditions, hemolysis and von Willebrand Factor multimers were similar to a commercial reference device after 6 h in vitro evaluation.
Antony P. McNamee +6 more
wiley +1 more source
Artificial Organs, EarlyView.In this large multicenter study, AF before LVAD implantation was not associated with increased risks of mortality, bleeding, stroke, or pump thrombosis, but was linked to a higher incidence of late VAs. ABSTRACT Introduction A substantial proportion of patients receiving left ventricular assist devices (LVADs) present with pre‐existing atrial ...
Miloud Cherbi +9 more
wiley +1 more source
, 1978 Monthly newsletter providing updates of interest to the Boston University School of Medicine ...
Boston University School of Medicine Office of Informational Services
core +3 more sources
Trial‐Based Hemolysis Modeling to Investigate Operating Modes of Continuous‐Flow LVADs
Artificial Organs, EarlyView.This work presents a methodology for determining online‐capable hemolysis models for continuous‐flow LVADs, derived from in vitro trials. The models are based on fitting a modified power law and applying the Lagrangian approach. They assist clinicians in selecting treatment strategies that minimize hemolysis, as demonstrated with the Sputnik1 LVAD ...
Patrick Borchers +2 more
wiley +1 more source
Percutaneous Intervention of LVAD Outflow Graft Obstruction and Thrombosis
Methodist DeBakey Cardiovascular JournalLeft ventricular assist devices serve as a salvage therapy for patients with advanced heart failure. Complications such as thrombosis and obstruction can lead to acute device malfunction, posing significant clinical risks. A multidisciplinary approach is
Andrew Takla +7 more
doaj +1 more source
ESC Heart Failure, 2022 Aims The removal of left ventricular assist device (LVAD) after myocardial recovery can provide survival benefits with freedom from LVAD‐associated complications.
Takayuki Gyoten +6 more
doaj +1 more source
Slope of the anterior mitral valve leaflet: A new measurement of left ventricular unloading for left ventricular assist devices and systolic dysfunction [PDF]
, 2014 Left ventricular assist device (LVAD)-supported patients are evaluated routinely with use of transthoracic echocardiography. Values of left ventricular unloading in this unique patient population are needed to evaluate LVAD function and assist in patient
Bradley, Elisa A +7 more
core +2 more sources
AI‐Assisted Decision‐Making for End‐Stage Organ Failure: Opportunities and Ethical Concerns
Artificial Organs, EarlyView.Artificial intelligence (AI) can help physicians make better decisions for people with serious organ problems by analyzing medical data to predict outcomes. Patients want AI to support, not replace, personal care from doctors. Collaboration among experts ensures AI tools respect patient values and privacy.
John W. Haller +2 more
wiley +1 more source
Mediators of Inflammation, 2013 Background. Inflammation is a critical process contributing to heart failure (HF). We hypothesized that IL-33/ST2 pathway, a new mechanism regulated during cardiac stress, may be involved in the functional worsening of end-stage HF patients, candidates ...
C. Caselli +11 more
doaj +1 more source